Reporting Date | Major Shareholder Name | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
05/10/2024 | VANGUARD GROUP INC | 541,329 | $6.36 M | 0.00% | 3.02% |
05/10/2024 | BLACKROCK INC. | 240,166 | $2.82 M | -6.89% | 1.34% |
05/08/2024 | MAI CAPITAL MANAGEMENT | 181,410 | $2.13 M | 85.09% | 1.01% |
05/14/2024 | RHENMAN & PARTNERS ASSET MANAGEMENT AB | 178,284 | $2.09 M | 0.00% | 0.99% |
05/13/2024 | GEODE CAPITAL MANAGEMENT, LLC | 170,802 | $2.01 M | 0.45% | 0.95% |
05/15/2024 | MILLENNIUM MANAGEMENT LLC | 159,192 | $1.87 M | 557.71% | 0.89% |
05/07/2024 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 154,834 | $1.82 M | 253.21% | 0.86% |
05/01/2024 | JANNEY MONTGOMERY SCOTT LLC | 140,911 | $1.66 M | -13.85% | 0.79% |
05/15/2024 | DEUTSCHE BANK AG\ | 109,848 | $1.29 M | 0.00% | 0.61% |
05/15/2024 | GOLDMAN SACHS GROUP INC | 87,605 | $1.03 M | 100.00% | 0.49% |
05/15/2024 | ROYAL BANK OF CANADA | 82,736 | $973,000 | 43.16% | 0.46% |
05/16/2024 | JANE STREET GROUP, LLC | 73,970 | $869,147 | 71.49% | 0.41% |
05/10/2024 | CITIGROUP INC | 48,044 | $564,517 | 33.83% | 0.27% |
05/15/2024 | STATE STREET CORP | 45,063 | $529,490 | 0.00% | 0.25% |
05/14/2024 | QUBE RESEARCH & TECHNOLOGIES LTD | 44,165 | $518,939 | 50.03% | 0.25% |
05/15/2024 | MAN GROUP PLC | 40,549 | $476,451 | 159.03% | 0.23% |
05/13/2024 | UBS GROUP AG | 38,300 | $450,025 | -11.37% | 0.21% |
04/19/2024 | WESTSIDE INVESTMENT MANAGEMENT, INC. | 34,390 | $404,084 | -17.86% | 0.19% |
05/15/2024 | LAIRD NORTON TRUST COMPANY, LLC | 31,500 | $370,125 | 0.00% | 0.18% |
04/12/2024 | FERMATA ADVISORS, LLC | 31,451 | $369,549 | 6.88% | 0.18% |
05/13/2024 | HRT FINANCIAL LP | 29,898 | $351,000 | 100.00% | 0.17% |
05/15/2024 | MORGAN STANLEY | 27,479 | $322,879 | 114.63% | 0.15% |
05/15/2024 | MARSHALL WACE, LLP | 26,825 | $315,194 | 100.00% | 0.15% |
04/25/2024 | BANK OF NEW YORK MELLON CORP | 26,089 | $306,546 | -21.89% | 0.15% |
05/07/2024 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 23,200 | $272,600 | -35.01% | 0.13% |
05/15/2024 | CITADEL ADVISORS LLC | 21,400 | $251,450 | 143.18% | 0.12% |
05/14/2024 | NORTHERN TRUST CORP | 20,417 | $239,900 | -18.56% | 0.11% |
05/13/2024 | BALYASNY ASSET MANAGEMENT L.P. | 20,047 | $235,552 | -13.81% | 0.11% |
05/15/2024 | BREVAN HOWARD CAPITAL MANAGEMENT LP | 16,422 | $192,959 | 100.00% | 0.09% |
05/10/2024 | MARATHON TRADING INVESTMENT MANAGEMENT LLC | 14,500 | $170,375 | 100.00% | 0.08% |
05/15/2024 | SQUAREPOINT OPS LLC | 13,441 | $157,932 | 100.00% | 0.07% |
05/15/2024 | POINT72 ASIA (SINGAPORE) PTE. LTD. | 13,438 | $157,897 | 100.00% | 0.07% |
05/10/2024 | ADVISOR GROUP HOLDINGS, INC. | 12,270 | $144,172 | 14.67% | 0.07% |
05/10/2024 | Y-INTERCEPT (HONG KONG) LTD | 11,059 | $129,943 | 100.00% | 0.06% |
05/15/2024 | LAURION CAPITAL MANAGEMENT LP | 11,011 | $129,379 | 0.00% | 0.06% |
05/01/2024 | FINANCIAL ADVOCATES INVESTMENT MANAGEMENT | 10,500 | $123,375 | -16.00% | 0.06% |
05/14/2024 | NEWEDGE ADVISORS, LLC | 10,475 | $123,081 | 0.48% | 0.06% |
05/14/2024 | BEACON POINTE ADVISORS, LLC | 10,368 | $121,824 | 0.00% | 0.06% |
05/10/2024 | LPL FINANCIAL LLC | 10,022 | $117,759 | -0.74% | 0.06% |
05/15/2024 | BANK OF AMERICA CORP /DE/ | 8,768 | $103,024 | -37.86% | 0.05% |
05/15/2024 | CUBIST SYSTEMATIC STRATEGIES, LLC | 4,782 | $56,189 | 100.00% | 0.03% |
05/15/2024 | CITADEL ADVISORS LLC | 3,500 | $41,125 | 84.21% | 0.02% |
05/15/2024 | TOWER RESEARCH CAPITAL LLC (TRC) | 2,255 | $26,496 | 47.00% | 0.01% |
04/19/2024 | VALLEY NATIONAL ADVISERS INC | 1,000 | $11,000 | 0.00% | 0.01% |
05/13/2024 | CONTINUUM ADVISORY, LLC | 1,000 | $10,770 | 100.00% | 0.01% |
05/13/2024 | FMR LLC | 585 | $6,874 | 588.24% | 0.00% |
05/14/2024 | CLEARSTEAD ADVISORS, LLC | 490 | $4,861 | 16.67% | 0.00% |
05/14/2024 | MACQUARIE GROUP LTD | 444 | $5 | 100.00% | 0.00% |
05/15/2024 | FEDERATION DES CAISSES DESJARDINS DU QUEBEC | 400 | $4,700 | 100.00% | 0.00% |
04/05/2024 | NBC SECURITIES, INC. | 270 | $3,000 | 0.00% | 0.00% |
A. During the previous two years, 71 institutional investors and hedge funds held shares of INmune Bio, Inc.. The most heavily invested institutionals were:
VANGUARD GROUP INC: 541,329
BlackRock Inc.: 240,166
MAI Capital Management: 181,410
Rhenman & Partners Asset Management AB: 178,284
GEODE CAPITAL MANAGEMENT, LLC: 170,802
MILLENNIUM MANAGEMENT LLC: 159,192
A. 15.26% of INmune Bio, Inc. stock is owned by institutional investors.
A. Institutional investors have bought a total of 3.44 M shares in the last 24 months. This purchase volume represents approximately $27.48 M in transactions.